Page last updated: 2024-11-02

pentobarbital and Cerebellar Diseases

pentobarbital has been researched along with Cerebellar Diseases in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanders, JE1
Yeary, RA1
Fenner, WR1
Powers, JD1

Other Studies

1 other study available for pentobarbital and Cerebellar Diseases

ArticleYear
Interaction of phenytoin with chloramphenicol or pentobarbital in the dog.
    Journal of the American Veterinary Medical Association, 1979, Jul-15, Volume: 175, Issue:2

    Topics: Administration, Oral; Animals; Cerebellar Diseases; Chloramphenicol; Dog Diseases; Dogs; Drug Intera

1979